Evidence check: Menopause Check in the context of fertility

The question of a 'Menopause Check' in the context of fertility requires a clear distinction between evidence and marketing. Tests measuring menopause markers like AMH (anti-Müllerian hormone) or FSH can provide clues about ovarian reserve, but they are not reliable predictors of current fertility or the exact timing of menopause. Evidence is moderate: AMH correlates with remaining egg count but does not guarantee pregnancy potential. FSH levels fluctuate with the menstrual cycle. Many home tests lack standardization and offer only a snapshot. For fertility assessment, clinical evaluation (ultrasound, cycle monitoring) is essential. Claiming that a menopause check can assess fertility is misleading. Evidence grade: human-moderate (for AMH/FSH as markers), but marketing-heavy in interpretation. Sources: No specific PMIDs in context; general fertility guidelines apply.